This week Mary and Alex discuss three articles covering a ground-breaking vaccine trial, heart transplant anti-rejection drug risks, and colon cancer diagnoses in young adults. There is some shocking news in each of these articles and this mother/daughter duo feels it’s very important to share what they’ve learned.
#Podcast #Spotify #Anchor #research #advocacy #vaccinetrial #cancerprevention #hearttransplant #immunosuppressantdrugs #antirejectiondrugs #coloncancer #youngadults #earlysymptoms #als #procterandgamble #mands
Stay Connected
Email Us: downthereaware@gmail.com
Instagram:@downthereaware
Facebook: Down There Aware
Twitter: @downthereaware
Pinterest: Down There Aware
TikTok: Down There Aware
Episode Links
Victoria's Secret From The B00BLESS BABE'S POV @Theebooblessbabe 💪😍 ... | TikTok
Amy Silverstein speaks up for change in drugs tied to organ transplants
https://twitter.com/CBSSunday/status/1655207103915589633
Is There a Lynch Syndrome Vaccine on the Way?
Colon cancer is on the rise in younger adults: What you should look for
Episode Highlights
Intro [0:13]
Welcome Back! [1:24]
Mary fumbling the beginning [1:35]
Bits of info in cyberspace [2:17]
Ground-breaking vaccine trial [3:13]
Lynch Syndrome [3:25]
First vaccine for non-viral disease [5:28]
Not a cure, but a prevention [5:50]
Kudos, MD Anderson [11:10]
Amy Silverstein [11:18]
Immunosuppressant drug risks [11:10]
Cloak of silence [12:54]
Life expectancy for heart transplant patients [15:34]
Under-funded research [16:15]
Brooke ALS [20:50]
Younger adults with colon cancer diagnoses [21:59]
Qualifications for colonoscopy [22:33]
Sadie Mae’s sneaky entrance [25:52]
Color-rectal cancer early symptoms [27:33]
Be your own advocate! [31:00]
Age is not the only factor. [32:56]
M & S packaging labels [33:13]
Procter & Gamble [33:36]
Thanks for listening! [35:14]
Summary Keywords
Podcast, Spotify, Anchor, research, advocacy, vaccine trial, cancer prevention, heart transplant, immunosuppressant drugs, anti-rejection drugs, colon cancer, young adults, early symptoms, Procter & Gamble, M & S, ALS
